Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Statistics

Total Valuation

FATE has a market cap or net worth of $110.00 million. The enterprise value is -$83.80 million.

Market Cap	110.00M
Enterprise Value	-83.80M

Important Dates

The last earnings date was Wednesday, March 5, 2025, after market close.

Earnings Date	Mar 5, 2025
Ex-Dividend Date	n/a

Share Statistics

FATE has 114.60 million shares outstanding. The number of shares has increased by 15.52% in one year.

Current Share Class	114.60M
Shares Outstanding	114.60M
Shares Change (YoY)	+15.52%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	77.75%
Float	99.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.01
Forward PS	23.42
PB Ratio	0.34
P/TBV Ratio	0.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.58, with a Debt / Equity ratio of 0.27.

Current Ratio	7.58
Quick Ratio	7.39
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.21% and return on invested capital (ROIC) is -27.90%.

Return on Equity (ROE)	-54.21%
Return on Assets (ROA)	-25.81%
Return on Invested Capital (ROIC)	-27.90%
Return on Capital Employed (ROCE)	-48.62%
Revenue Per Employee	$75,309
Profits Per Employee	-$1.03M
Employee Count	181
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.18% in the last 52 weeks. The beta is 2.26, so FATE's price volatility has been higher than the market average.

Beta (5Y)	2.26
52-Week Price Change	-88.18%
50-Day Moving Average	1.35
200-Day Moving Average	2.83
Relative Strength Index (RSI)	37.43
Average Volume (20 Days)	3,330,297

Short Selling Information

The latest short interest is 13.06 million, so 11.40% of the outstanding shares have been sold short.

Short Interest	13.06M
Short Previous Month	12.87M
Short % of Shares Out	11.40%
Short % of Float	13.07%
Short Ratio (days to cover)	8.34

Income Statement

In the last 12 months, FATE had revenue of $13.63 million and -$186.26 million in losses. Loss per share was -$1.64.

Revenue	13.63M
Gross Profit	-104.90M
Operating Income	-195.54M
Pretax Income	-190.05M
Net Income	-186.26M
EBITDA	-176.58M
EBIT	-195.54M
Loss Per Share	-$1.64

Balance Sheet

The company has $279.07 million in cash and $85.27 million in debt, giving a net cash position of $193.80 million or $1.69 per share.

Cash & Cash Equivalents	279.07M
Total Debt	85.27M
Net Cash	193.80M
Net Cash Per Share	$1.69
Equity (Book Value)	318.73M
Book Value Per Share	2.80
Working Capital	253.39M

Cash Flow

In the last 12 months, operating cash flow was -$122.87 million and capital expenditures -$730,000, giving a free cash flow of -$123.60 million.

Operating Cash Flow	-122.87M
Capital Expenditures	-730,000
Free Cash Flow	-123.60M
FCF Per Share	-$1.08

Margins

Gross Margin	n/a
Operating Margin	-1,434.52%
Pretax Margin	-1,366.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FATE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.52%
Shareholder Yield	-15.52%
Earnings Yield	-169.33%
FCF Yield	-112.37%

Analyst Forecast

The average price target for FATE is $5.50, which is 472.98% higher than the current price. The consensus rating is "Hold".

Price Target	$5.50
Price Target Difference	472.98%
Analyst Consensus	Hold
Analyst Count	9
Revenue Growth Forecast (5Y)	53.86%
EPS Growth Forecast (5Y)	-22.14%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FATE has an Altman Z-Score of -2.92 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.92
Piotroski F-Score	1